OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+109.06%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$510M
AUM Growth
+$233M
(+84%)
Cap. Flow
+$74.8M
Cap. Flow
% of AUM
14.68%
Top 10 Holdings %
Top 10 Hldgs %
42.94%
Holding
56
New
7
Increased
29
Reduced
8
Closed
9
Top Buys
| 1 |
APTO
Aptose Biosciences, Inc.
APTO
|
$19.1M |
| 2 |
Ocular Therapeutix
OCUL
|
$9.21M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$8.12M |
| 4 |
EDAP
EDAP TMS
EDAP
|
$6.58M |
| 5 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$6.43M |
Top Sells
| 1 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$8.04M |
| 2 |
Cytokinetics
CYTK
|
$7.4M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$4.79M |
| 4 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$2.93M |
| 5 |
NextCure
NXTC
|
$2.62M |
Sector Composition
| 1 | Healthcare | 90.15% |